ImmuCell Corporation (NASDAQ:ICCC) Q4 2022 Earnings Call Transcript February 22, 2023
Operator: Good morning, and welcome to ImmuCell Corporation Reports Fiscal Year 2022 Unaudited Financial Results Conference Call. All participants will be in a listen-only mode. After today’s presentation there will be an opportunity to ask questions. Please note that this event is being recorded today. I would now like to turn the conference over to Joe Diaz of Lytham Partners. Please go ahead.
Joe Diaz:...
